Mumbai, Dec. 30 -- Lupin has entered into an exclusive License, Supply and Distribution agreement with Gan & Lee Pharmaceuticals, headquartered in China, for a novel fortnightly GLP-1 receptor agonist, Bofanglutide.

Published by HT Digital Content Services with permission from Capital Market....